bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2023,
Номер
unknown
Опубликована: Сен. 22, 2023
Summary
Temporally
controlling
cre
recombination
through
tamoxifen
(Tam)
induction
has
many
advantages
for
biomedical
research.
Most
studies
report
Tam
at
early
post-natal/juvenile
(<2
m.o.)
mouse
ages,
but
age-related
neurodegeneration
and
aging
can
require
in
older
mice
(>12
m.o.).
While
anecdotally
reported
as
problematic,
there
are
no
published
comparisons
of
mediated
late
ages.
Here,
microglial-specific
Cx3cr1
creERT
2
were
crossed
to
a
floxed
NuTRAP
reporter
compare
(3-6
(20
Specificity
efficiency
microglial
labeling
21-22
m.o.
identical
induced
with
3-6
or
20
age.
Age-related
translatomic
changes
also
similar
regardless
Each
flox
line
should
be
validated
independently,
however,
these
findings
demonstrate
that
Tam-mediated
performed
even
into
iScience,
Год журнала:
2023,
Номер
26(12), С. 108413 - 108413
Опубликована: Ноя. 9, 2023
Temporally
controlling
Cre
recombination
through
tamoxifen
(Tam)
induction
has
many
advantages
for
biomedical
research.
Most
studies
report
early
post-natal/juvenile
(<2
m.o.)
Tam
induction,
but
age-related
neurodegeneration
and
aging
can
require
in
older
mice
(>12
m.o.).
While
anecdotally
reported
as
problematic,
there
are
no
published
comparisons
of
Tam-mediated
at
late
ages.
Here,
microglial-specific
Cx3cr1creERT2
were
crossed
to
a
floxed
NuTRAP
reporter
compare
(3-6
(20
Specificity
efficiency
microglial
labeling
21-22
m.o.
identical
induced
with
Age-related
translatomic
changes
also
similar
regardless
age.
Each
flox
mouse
line
should
be
independently
validated,
however,
these
findings
demonstrate
that
performed
even
into
ages
generalizable
other
inducible
models.
Journal of Neurophysiology,
Год журнала:
2024,
Номер
132(3), С. 929 - 942
Опубликована: Авг. 20, 2024
Alzheimer’s
disease
(AD)
was
described
more
than
a
century
ago.
However,
there
are
still
no
effective
approaches
to
its
treatment,
which
may
suggest
that
the
search
for
cure
is
not
being
conducted
in
most
productive
direction.
AD
begins
as
selective
impairments
of
declarative
memory
with
deficits
other
cognitive
functions.
Therefore,
understanding
pathogenesis
has
include
this
selectivity.
Currently,
main
efforts
aimed
at
prevention
and
treatment
based
on
dominating
hypothesis
pathogenesis:
amyloid
hypothesis.
But
does
explain
since
β-amyloid
accumulates
extracellularly
should
be
toxic
all
types
cerebral
neurons,
only
“memory
engram
neurons.”
To
impairment,
I
propose
autoimmune
AD,
analysis
risk
factors
molecular
mechanisms
formation.
Memory
formation
associated
epigenetic
modifications
chromatin
neurons
and,
therefore,
might
accompanied
by
expression
memory-specific
proteins
recognized
adaptive
immune
system
“non-self”
antigens.
Normally,
brain
protected
blood-brain
barrier
(BBB).
All
provoke
BBB
disruptions,
possibly
leading
an
reaction
against
neurons.
This
would
make
them
selectively
sensitive
tauopathy.
If
confirmed,
strategies
radically
changed.
Frontiers in Neuroscience,
Год журнала:
2024,
Номер
18
Опубликована: Дек. 9, 2024
In
recent
years,
increasing
evidence
has
highlighted
the
critical
role
of
myeloid
cells,
specifically
those
that
present
antigen
(APCs)
in
health
and
disease.
These
shape
progression
development
neurodegenerative
disorders,
where
considerable
interplay
between
immune
system
neurons
influences
course
disease
pathogenesis.
Antigen-presenting
cells
display
different
classes
major
histocompatibility
complex
(MHC)
MHC-like
proteins
on
their
surface
for
presenting
various
types
antigens
to
a
wide
variety
T
cells.
While
most
studies
focus
MHC
class
I
II
molecules
disease,
there
is
still
much
remains
unknown
about
non-polymorphic
such
as
CD1d
MR1.
Thus,
this
review,
we
will
summarize
findings
regarding
contributions
both
classical
non-classical
molecules,
particularly
microglial
APCs,
diseases.
This
offer
better
understanding
altered
mechanisms
may
pave
way
novel
therapeutic
strategies
targeting
cell-MHC
interactions,
mitigate
neurodegeneration
its
associated
pathology.
bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2023,
Номер
unknown
Опубликована: Сен. 22, 2023
Summary
Temporally
controlling
cre
recombination
through
tamoxifen
(Tam)
induction
has
many
advantages
for
biomedical
research.
Most
studies
report
Tam
at
early
post-natal/juvenile
(<2
m.o.)
mouse
ages,
but
age-related
neurodegeneration
and
aging
can
require
in
older
mice
(>12
m.o.).
While
anecdotally
reported
as
problematic,
there
are
no
published
comparisons
of
mediated
late
ages.
Here,
microglial-specific
Cx3cr1
creERT
2
were
crossed
to
a
floxed
NuTRAP
reporter
compare
(3-6
(20
Specificity
efficiency
microglial
labeling
21-22
m.o.
identical
induced
with
3-6
or
20
age.
Age-related
translatomic
changes
also
similar
regardless
Each
flox
line
should
be
validated
independently,
however,
these
findings
demonstrate
that
Tam-mediated
performed
even
into